Cite
HARVARD Citation
McConeghy, K. et al. (2014). Evaluation of Dabigatran Bleeding Adverse Reaction Reports in the FDA Adverse Event Reporting System during the First Year of Approval. Pharmacotherapy. 34 (6), pp. 561-569. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
McConeghy, K. et al. (2014). Evaluation of Dabigatran Bleeding Adverse Reaction Reports in the FDA Adverse Event Reporting System during the First Year of Approval. Pharmacotherapy. 34 (6), pp. 561-569. [Online].